Human papillomavirus genotyping using HPV DNA chip analysis in Korean women

International Journal of Gynecological Cancer

Volumn 17, Issue 2, 2007, Pages 497-501

  Lee, H S ^a   Kim, K M ^a   Kim, S M ^a   Choi, Y D ^a   Nam, J H ^a   Park, C S ^a   Choi, H S ^a  

^a Chonnam National University Medical School   (South Korea)

Author keywords

Cervical neoplasia; HPV DNA chip test; Human papillomavirus; Korean women

Indexed keywords

ADULT; AGED; ARTICLE; CANCER RISK; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DNA DETERMINATION; FEMALE; GENOTYPE; GEOGRAPHIC DISTRIBUTION; HISTOLOGY; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 33; HUMAN PAPILLOMAVIRUS TYPE 58; HUMAN TISSUE; KOREA; MAJOR CLINICAL STUDY; PREDICTION AND FORECASTING; PREVALENCE; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; SQUAMOUS CELL METAPLASIA; STATISTICAL SIGNIFICANCE; UTERINE CERVICITIS; UTERINE CERVIX BIOPSY; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CYTOLOGY; WART VIRUS;

ALPHAPAPILLOMAVIRUS; CERVICAL INTRAEPITHELIAL NEOPLASIA; DNA PROBES, HPV; FEMALE; HUMANS; KOREA; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PAPILLOMAVIRUS INFECTIONS; PREVALENCE; SENSITIVITY AND SPECIFICITY; UTERINE CERVICAL NEOPLASMS;

EID: 33947241828     PISSN: 1048891X     EISSN: 15251438     Source Type: Journal    
DOI: 10.1111/j.1525-1438.2007.00871.x     Document Type: Article

References (32)

1. Parkin DM, Whelan SL, Ferlay J, Raymond L, Young J. Cancer incidence in five continents, VII. IARC Scientific Publication No. 143. Lyon, France: International Agency for Research on Cancer, 1997.
2. Bosch FX, Manos MM, Munoz N et al. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. J Natl Cancer Inst 1995;87:796-802.
3. Devilliers EM. Heterogeneity of the human papilloma virus group. J Virol 1989;63:4898-903.
4. Brown DR, McClowry TL, Woods K, Fife KH. Nucleotide sequence and characterization of human papilloma virus type 83, a novel genital papillomavirus. Virology 1999;260:165-72.
5. Herrero R, Hildesheim A, Bratti C. Population-based study of human papilloma virus infection and cervical neoplasia in rural Costa Rica. J Natl Cancer Inst 2000;92:464-74.
6. An HJ, Cho NH, Lee SY et al. Correlation of cervical carcinoma and precancerous lesions with human papillomavirus (HPV) genotypes detected with the HPV DNA chip microarray method. Cancer 2003;97:1672-80.
7. Choi YD, Jung WW, Nam JH, Choi HS, Park CS. Detection of HPV genotypes in cervical lesions by the HPV DNA Chip and sequencing. Gynecol Oncol 2005;98:369-75.
8. Bosch FX, Munoz N, De Sanjose S. Risk factors for cervical cancer in Colombia and Spain. Int J Cancer 1992;52:750-8.
9. Becker TM, Wheeler CM, McGough NS. Sexually transmitted diseases and other risk factors for cervical dysplasia among Southwestern Hispanic and non-Hispanic white women. JAMA 1994;271:1181-8.
10. Saslow D, Runowicz CD, Solomon D, Moscicki AB, Smith RA, Eyre HJ. American Cancer Society guideline for the early detection of cervical neoplasia and cancer. CA Cancer J Clin 2002;52:342-62.
11. Cervical cytology screening. ACOG Practice Bulletin No. 45. American College of Obstetricians and Gynecologists. Obstet Gynecol 2003;102:417-27.
12. Solomon D, Schiffman M, Tarone R. Comparison of three management strategies for patients with atypical squamous cells of undetermined significance: baseline results from a randomized trial. J Natl Cancer Inst 2001;93:293-9.
13. Takahashi Y, Yamade I, Nakamura T. Infection by human papilloma virus types 6, 11, 16, 18, 31, 33 and 35 of the cervix in Japanese women. Int J Gynecol Cancer 1995;5:45-8.
14. Lorincz AT, Temple GF, Kurman J. Oncogenic association of specific human papilloma virus types with cervical neoplasia. J Natl Cancer Inst 1987;79:671-7.
15. Sowjanya AP, Jain M, Poli UR et al. Prevalence and distribution of high-risk human papilloma virus (HPV) types in invasive squamous cell carcinoma of the cervix and in normal women in Andhra Pradesh, India. BMC Infect Dis 2005;22:116.
16. Hammouda D, Munoz N, Herrero R et al. Cervical carcinoma in Algiers, Algeria: human papillomavirus and lifestyle risk factors. Int J Cancer 2005;113:483-9.
17. Kay P, Soeters R, Nevin J, Denny L, Dehaeck CM, Williamson AL. High prevalence of HPV 16 in South African women with cancer of the cervix and cervical intraepithelial neoplasia. J Med Virol 2003;71:265-73.
18. Stanczuk GA, Kay P, Sibanda E et al. Typing of human papillomavirus in Zimbabwean patients with invasive cancer of the uterine cervix. Acta Obstet Gynecol Scand 2003;82:762-6.
19. Jeng CJ, Phdl Ko ML et al. Prevalence of cervical human papillomavirus in Taiwanese women. Clin Invest Med 2005;28:261-6.
20. Lungu O, Sun XW, Felix J. Relationship of human papilloma virus type to grade of cervical intraepithelial neoplasia. JAMA 1992;267:2493-6.
21. Fife KH, Cramer HM, Schroeder JM, Brown DR. Detection of multiple human papilloma virus types in the lower genital tract correlates with cervical dysplasia. J Med Virol 2001;64:550-9.
22. Bergeron CA, Ferenczy A, Sah KV, Naghashfar Z. Multicentric human papilloma virus infections of the female genital tract: correlation of viral types with abnormal mitotic figures, colposcopic presentation, and location. Obstet Gynecol 1987;69:736-42.
23. Reid RM, Greenberg AB, Jenson M. Sexually transmitted papilloma viral infections: the anatomic distribution and pathologic grade of neoplastic lesions associated with different viral types. Am J Obstet Gynecol 1987;156:212-22.
24. Schneider A, Kraus H, Schuhmann R, Gissmann L. Papilloma virus infection of the lower genital tract: detection of viral DNA in gynecological swabs. Int J Cancer 1985;35:443-8.
25. ALTS Group. Human papilloma virus testing for triage of women with cytologic evidence of low-grade squamous intraepithelial lesions: baseline data from a randomized trial. J Natl Cancer Inst 2000;92:397.
26. Cox JT, Lorincz AT, Schiffman MH. Human papilloma virus testing by hybrid capture appears to be useful in triaging women with a cytologic diagnosis of atypical squamous cells of undetermined significance. Am J Obstet Gynecol 1995;172:946-54.
27. Cuzick J, Szarewski A, Terry G. Human papilloma virus testing in primary cervical screening. Lancet 1995;345:1533-7.
28. Segal A, Frost FA, Miranda A, Fletcher C, Sterrett GF. Predictive value of diagnoses of endocervical glandular abnormalities in cervical smears. Pathology 2003;35:198-203.
29. Nobbenhuis M, Meijer CJLM, van den Brule AJC. Addition of highrisk HPV testing improves the current guidelines on follow-up after treating for cervical intraepithelial neoplasia. Br J Cancer 2001;84:796-801.
30. Travers H. Quality assurance indicators in anatomic pathology. Arch Pathol Lab Med 1990;114:1149-56.
31. Schneider A, Hoyer H, Lotz B et al. Screening for high-grade cervical intra-epithelial neoplasia and cancer by testing for high-risk HPV, routine cytology or colposcopy. Int J Cancer 2000;89:529-34.
32. Lee KJ, Lee JK, Saw HS. Can human papillomavirus DNA testing substitute for cytology in the detection of high-grade cervical lesions? Arch Pathol Lab Med 2004;128:298-302.